H M Mehanna

Summary

Affiliation: University Hospitals Coventry and Warwickshire
Country: UK

Publications

  1. doi Postoperative hypocalcemia--the difference a definition makes
    Hisham M Mehanna
    Institute of Head and Neck Studies and Education, University Hospital, Coventry, United Kingdom
    Head Neck 32:279-83. 2010
  2. doi Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer--systematic review and meta-analysis of trends by time and region
    Hisham Mehanna
    Institute of Head and Neck Studies and Education, Coventry, United Kingdom
    Head Neck 35:747-55. 2013
  3. doi Treatment and follow-up of oral dysplasia - a systematic review and meta-analysis
    Hisham M Mehanna
    Department of Head and Neck Surgery, Institute of Head and Neck Studies and Education, University Hospitals Coventry and Warwickshire, Coventry, United Kingdom
    Head Neck 31:1600-9. 2009
  4. pmc Refeeding syndrome: what it is, and how to prevent and treat it
    Hisham M Mehanna
    Institute of Head and Neck Studies and Education, Department of Otorhinolaryngology Head and Neck Surgery, University Hospital, Coventry CV2 2DX
    BMJ 336:1495-8. 2008
  5. doi The association of psycho-social factors and survival in head and neck cancer
    H M Mehanna
    Institute of Head and Neck Studies and Education, Department of Otolaryngology, University Hospitals Coventry and Warwick NHS Trust, Coventry, UK
    Clin Otolaryngol 33:83-9. 2008
  6. ncbi Will measuring quality of life in head and neck cancer alter individuals' treatment?
    Hisham M Mehanna
    Department of Otolaryngology, University Hospitals Coventry and Warwickshire, Coventry and Heart of England Foundation Trust, Birmingham, UK
    Curr Opin Otolaryngol Head Neck Surg 15:57-62. 2007
  7. ncbi Facial palsy as the presenting complaint of perineural spread from cutaneous squamous cell carcinoma of the head and neck
    Hisham M Mehanna
    Auckland Regional Head Neck Unit, Auckland City Hospital, Auckland, New Zealand
    ANZ J Surg 77:191-3. 2007
  8. ncbi Patients' views on the utility of quality of life questionnaires in head and neck cancer: a randomised trial
    H M Mehanna
    Department of Head and Neck Surgery, University Hospitals Coventry and Warwickshire, Coventry, UK
    Clin Otolaryngol 31:310-6. 2006
  9. ncbi Deterioration in quality-of-life of late (10-year) survivors of head and neck cancer
    H M Mehanna
    Department of Head and Neck Surgery, University Hospitals Coventry and Warwickshire, Coventry, UK
    Clin Otolaryngol 31:204-11. 2006
  10. ncbi Why are head and neck cancer clinicians not measuring quality of life?
    H M Mehanna
    Department of Head and Neck Surgery, University Hospitals Coventry and Warwickshire, Coventry, the Birmingham Heartlands Hospital, Birmingham, UK
    J Laryngol Otol 120:861-4. 2006

Detail Information

Publications13

  1. doi Postoperative hypocalcemia--the difference a definition makes
    Hisham M Mehanna
    Institute of Head and Neck Studies and Education, University Hospital, Coventry, United Kingdom
    Head Neck 32:279-83. 2010
    ..It also prevents the pooling of data when performing meta-analysis, and may affect the comparison of research results...
  2. doi Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer--systematic review and meta-analysis of trends by time and region
    Hisham Mehanna
    Institute of Head and Neck Studies and Education, Coventry, United Kingdom
    Head Neck 35:747-55. 2013
    ..Little information has been reported on regional and time trends of human papillomavirus (HPV) prevalence rates of oropharyngeal cancer (OPC) and non-OPC...
  3. doi Treatment and follow-up of oral dysplasia - a systematic review and meta-analysis
    Hisham M Mehanna
    Department of Head and Neck Surgery, Institute of Head and Neck Studies and Education, University Hospitals Coventry and Warwickshire, Coventry, United Kingdom
    Head Neck 31:1600-9. 2009
    ..The aim of this study was to inform an evidence-based management policy for oral dysplastic lesions...
  4. pmc Refeeding syndrome: what it is, and how to prevent and treat it
    Hisham M Mehanna
    Institute of Head and Neck Studies and Education, Department of Otorhinolaryngology Head and Neck Surgery, University Hospital, Coventry CV2 2DX
    BMJ 336:1495-8. 2008
  5. doi The association of psycho-social factors and survival in head and neck cancer
    H M Mehanna
    Institute of Head and Neck Studies and Education, Department of Otolaryngology, University Hospitals Coventry and Warwick NHS Trust, Coventry, UK
    Clin Otolaryngol 33:83-9. 2008
    ..Update a previous review examining associations between psycho-social factors and survival in head and neck cancer patients...
  6. ncbi Will measuring quality of life in head and neck cancer alter individuals' treatment?
    Hisham M Mehanna
    Department of Otolaryngology, University Hospitals Coventry and Warwickshire, Coventry and Heart of England Foundation Trust, Birmingham, UK
    Curr Opin Otolaryngol Head Neck Surg 15:57-62. 2007
    ..To examine the ways in which quality of life assessment has been and can be used in the future to benefit patient care...
  7. ncbi Facial palsy as the presenting complaint of perineural spread from cutaneous squamous cell carcinoma of the head and neck
    Hisham M Mehanna
    Auckland Regional Head Neck Unit, Auckland City Hospital, Auckland, New Zealand
    ANZ J Surg 77:191-3. 2007
  8. ncbi Patients' views on the utility of quality of life questionnaires in head and neck cancer: a randomised trial
    H M Mehanna
    Department of Head and Neck Surgery, University Hospitals Coventry and Warwickshire, Coventry, UK
    Clin Otolaryngol 31:310-6. 2006
    ....
  9. ncbi Deterioration in quality-of-life of late (10-year) survivors of head and neck cancer
    H M Mehanna
    Department of Head and Neck Surgery, University Hospitals Coventry and Warwickshire, Coventry, UK
    Clin Otolaryngol 31:204-11. 2006
    ..To determine 10-year quality-of-life (QOL) in head and neck cancer patients and to examine the potential predictors of late QOL...
  10. ncbi Why are head and neck cancer clinicians not measuring quality of life?
    H M Mehanna
    Department of Head and Neck Surgery, University Hospitals Coventry and Warwickshire, Coventry, the Birmingham Heartlands Hospital, Birmingham, UK
    J Laryngol Otol 120:861-4. 2006
    ..To quantify and qualify the use of quality of life (QOL) measures by head and neck cancer clinicians and to identify any impediments to the use of these measures...
  11. doi The risk and interval to malignancy of patients with laryngeal dysplasia; a systematic review of case series and meta-analysis
    M D Weller
    Institute of Head and Neck Studies and Education, University Hospitals Coventry and Warwickshire, Coventry, UK
    Clin Otolaryngol 35:364-72. 2010
    ..Laryngeal dysplasia is a pre-malignant condition with wide variability in rates of malignant transformation reported in the literature. The management and follow-up strategies of these lesions vary widely...
  12. doi A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy
    M G Isles
    Institute of Head and Neck Studies and Education, Department of Otorhinolaryngology Head Neck Surgery, University Hospital, Coventry, UK
    Clin Otolaryngol 33:210-22. 2008
    ..This review examines the effectiveness of positron emission tomography (PET) in the detection of recurrent or persistent head and neck squamous cell carcinoma after radiotherapy or chemoradiotherapy...
  13. ncbi Does quality of life predict long-term survival in patients with head and neck cancer?
    Hisham M Mehanna
    Department of Otorhinolaryngology Head and Neck Surgery, University Hospitals Coventry and Warwickshire, Coventry, England
    Arch Otolaryngol Head Neck Surg 132:27-31. 2006
    ..To assess whether pretreatment and posttreatment quality of life (QOL) is associated with long-term survival in patients with head and neck cancer...